Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature Communications

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://ir.gritstonebio.com/news-releases/news-release-details/gritstone-bio-announces-publication-interim-results-phase-1
Research Institution
Gritstone bio
Short Title
Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature Communications
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald